Vaxart (English Wikipedia)

"Polio Vaccination: What Everyone Should Know". National Center for Immunization and Respiratory Diseases, US Centers for Disease Control and Prevention. May 4, 2018. Retrieved 5 March 2020.

delaware.gov (Global: 6,775^th place; English: 3,885^th place)

courts.delaware.gov

"In re Vaxart, Inc. Stockholder Litigation". Delaware Court of Chancery. January 18, 2024. Retrieved February 1, 2025.

doi.org (Global: 2^nd place; English: 2^nd place)

Zheng, Zhichao; Diaz-Arévalo, Diana; Guan, Hongbing; Zeng, Mingtao (17 May 2018). "Noninvasive vaccination against infectious diseases (Review)". Human Vaccines & Immunotherapeutics. 14 (7): 1717–1733. doi:10.1080/21645515.2018.1461296. ISSN 2164-5515. PMC 6067898. PMID 29624470.
Fast, Patricia E; Cox, Josephine H (1 September 2015). "An influenza vaccine pill - can we swallow it?". The Lancet Infectious Diseases. 15 (9): 1051–6, discussion 1056–7. doi:10.1016/s1473-3099(15)00252-2. PMID 2633331. Retrieved 27 January 2020.
Bandyopadhyay, Ananda S; Modlin, John F; Wenger, Jay; Gast, Chris (30 October 2018). "Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review". Clinical Infectious Diseases. 67 (suppl_1): S35–S41. doi:10.1093/cid/ciy633. ISSN 1058-4838. PMC 6206125. PMID 30376081.
SN Tucker; DW Tingley; CD Scallan (2008). "Oral adenovirus-based vaccines: historical perspective and future opportunity". Expert Review of Vaccines. 7 (1): 25–31. doi:10.1586/14760584.7.1.25. ISSN 1476-0584. PMID 18251691. S2CID 7058518. Retrieved 1 March 2020.
Liebowitz, David; Lindbloom, Jonathan D; Brandl, Jennifer R; Garg, Shaily J; Tucker, Sean N (2015). "High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial". The Lancet Infectious Diseases. 15 (9). Elsevier BV: 1041–1048. doi:10.1016/s1473-3099(15)00266-2. ISSN 1473-3099. PMID 26333337.
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N (2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet Infectious Diseases. 20 (4): 435–444. doi:10.1016/s1473-3099(19)30584-5. ISSN 1473-3099. PMID 31978354. S2CID 210892802.

insidermonkey.com (Global: low place; English: low place)

Debasis Saha (December 22, 2019). "Hedge funds have never been this bullish on Vaxart, Inc. (VXRT)". Hedge Fund News, Insider Monkey. Retrieved 1 March 2020.

nasdaq.com (Global: 2,740^th place; English: 2,050^th place)

"Vaxart (VXRT) - A long shot or perfect shot?". NASDAQ, RTTNews.com. 25 February 2020. Retrieved 1 March 2020.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Zheng, Zhichao; Diaz-Arévalo, Diana; Guan, Hongbing; Zeng, Mingtao (17 May 2018). "Noninvasive vaccination against infectious diseases (Review)". Human Vaccines & Immunotherapeutics. 14 (7): 1717–1733. doi:10.1080/21645515.2018.1461296. ISSN 2164-5515. PMC 6067898. PMID 29624470.
Fast, Patricia E; Cox, Josephine H (1 September 2015). "An influenza vaccine pill - can we swallow it?". The Lancet Infectious Diseases. 15 (9): 1051–6, discussion 1056–7. doi:10.1016/s1473-3099(15)00252-2. PMID 2633331. Retrieved 27 January 2020.
Bandyopadhyay, Ananda S; Modlin, John F; Wenger, Jay; Gast, Chris (30 October 2018). "Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review". Clinical Infectious Diseases. 67 (suppl_1): S35–S41. doi:10.1093/cid/ciy633. ISSN 1058-4838. PMC 6206125. PMID 30376081.
SN Tucker; DW Tingley; CD Scallan (2008). "Oral adenovirus-based vaccines: historical perspective and future opportunity". Expert Review of Vaccines. 7 (1): 25–31. doi:10.1586/14760584.7.1.25. ISSN 1476-0584. PMID 18251691. S2CID 7058518. Retrieved 1 March 2020.
Liebowitz, David; Lindbloom, Jonathan D; Brandl, Jennifer R; Garg, Shaily J; Tucker, Sean N (2015). "High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial". The Lancet Infectious Diseases. 15 (9). Elsevier BV: 1041–1048. doi:10.1016/s1473-3099(15)00266-2. ISSN 1473-3099. PMID 26333337.
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N (2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet Infectious Diseases. 20 (4): 435–444. doi:10.1016/s1473-3099(19)30584-5. ISSN 1473-3099. PMID 31978354. S2CID 210892802.

ncbi.nlm.nih.gov

Zheng, Zhichao; Diaz-Arévalo, Diana; Guan, Hongbing; Zeng, Mingtao (17 May 2018). "Noninvasive vaccination against infectious diseases (Review)". Human Vaccines & Immunotherapeutics. 14 (7): 1717–1733. doi:10.1080/21645515.2018.1461296. ISSN 2164-5515. PMC 6067898. PMID 29624470.
Bandyopadhyay, Ananda S; Modlin, John F; Wenger, Jay; Gast, Chris (30 October 2018). "Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review". Clinical Infectious Diseases. 67 (suppl_1): S35–S41. doi:10.1093/cid/ciy633. ISSN 1058-4838. PMC 6206125. PMID 30376081.

polioeradication.org (Global: low place; English: low place)

"Polio: Global Eradication Initiative". Global Polio Eradication Initiative, World Health Organization. 2020. Retrieved 5 March 2020.

researchgate.net (Global: 120^th place; English: 125^th place)

SN Tucker; DW Tingley; CD Scallan (2008). "Oral adenovirus-based vaccines: historical perspective and future opportunity". Expert Review of Vaccines. 7 (1): 25–31. doi:10.1586/14760584.7.1.25. ISSN 1476-0584. PMID 18251691. S2CID 7058518. Retrieved 1 March 2020.

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

SN Tucker; DW Tingley; CD Scallan (2008). "Oral adenovirus-based vaccines: historical perspective and future opportunity". Expert Review of Vaccines. 7 (1): 25–31. doi:10.1586/14760584.7.1.25. ISSN 1476-0584. PMID 18251691. S2CID 7058518. Retrieved 1 March 2020.
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N (2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet Infectious Diseases. 20 (4): 435–444. doi:10.1016/s1473-3099(19)30584-5. ISSN 1473-3099. PMID 31978354. S2CID 210892802.

thelancet.com (Global: 2,393^rd place; English: 3,174^th place)

Fast, Patricia E; Cox, Josephine H (1 September 2015). "An influenza vaccine pill - can we swallow it?". The Lancet Infectious Diseases. 15 (9): 1051–6, discussion 1056–7. doi:10.1016/s1473-3099(15)00252-2. PMID 2633331. Retrieved 27 January 2020.
Liebowitz, David; Lindbloom, Jonathan D; Brandl, Jennifer R; Garg, Shaily J; Tucker, Sean N (2015). "High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial". The Lancet Infectious Diseases. 15 (9). Elsevier BV: 1041–1048. doi:10.1016/s1473-3099(15)00266-2. ISSN 1473-3099. PMID 26333337.
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N (2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet Infectious Diseases. 20 (4): 435–444. doi:10.1016/s1473-3099(19)30584-5. ISSN 1473-3099. PMID 31978354. S2CID 210892802.

vaxart.com (Global: low place; English: low place)

investors.vaxart.com

"FORM 10-K". December 31, 2023. Retrieved July 12, 2024.
"Vaxart, Inc. 2023 10-K Filing". Vaxart, Inc. March 15, 2023. Retrieved January 29, 2024.
"Vaxart, Inc. 2023 10-K Filing". Vaxart, Inc. March 15, 2023. Retrieved January 29, 2024.
"Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate". Vaxart, Inc. January 19, 2024. Retrieved January 29, 2024.
"Vaxart Announces Favorable DSMB Review Sentinel Cohort Covid 19". Vaxart, Inc. January 13, 2025. Retrieved February 1, 2025.
"Vaxart Announces Collaborative Funding from Leading Foundation to Study Its Norovirus Vaccine Candidate in Breastfeeding Mothers". GlobeNewswire. December 1, 2022. Retrieved January 29, 2024.
"Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus Vaccine Candidate in Lactating Mothers". GlobeNewswire. November 2, 2023. Retrieved January 29, 2024.
"Vaxart Announces Positive Preliminary Topline Data from Dose-Ranging Phase 2 Study of its Bivalent Norovirus Vaccine Candidate". GlobeNewswire. July 6, 2023. Retrieved January 29, 2024.
"Vaxart Announces Topline Data from the Phase 2 Challenge Study of its Monovalent Norovirus Vaccine Candidate". GlobeNewswire. September 6, 2023. Retrieved January 29, 2024.

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Zheng, Zhichao; Diaz-Arévalo, Diana; Guan, Hongbing; Zeng, Mingtao (17 May 2018). "Noninvasive vaccination against infectious diseases (Review)". Human Vaccines & Immunotherapeutics. 14 (7): 1717–1733. doi:10.1080/21645515.2018.1461296. ISSN 2164-5515. PMC 6067898. PMID 29624470.
Bandyopadhyay, Ananda S; Modlin, John F; Wenger, Jay; Gast, Chris (30 October 2018). "Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review". Clinical Infectious Diseases. 67 (suppl_1): S35–S41. doi:10.1093/cid/ciy633. ISSN 1058-4838. PMC 6206125. PMID 30376081.
SN Tucker; DW Tingley; CD Scallan (2008). "Oral adenovirus-based vaccines: historical perspective and future opportunity". Expert Review of Vaccines. 7 (1): 25–31. doi:10.1586/14760584.7.1.25. ISSN 1476-0584. PMID 18251691. S2CID 7058518. Retrieved 1 March 2020.
Liebowitz, David; Lindbloom, Jonathan D; Brandl, Jennifer R; Garg, Shaily J; Tucker, Sean N (2015). "High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial". The Lancet Infectious Diseases. 15 (9). Elsevier BV: 1041–1048. doi:10.1016/s1473-3099(15)00266-2. ISSN 1473-3099. PMID 26333337.
Liebowitz, David; Gottlieb, Keith; Kolhatkar, Nikita S; Garg, Shaily J; Asher, Jason M; Nazareno, Jonathan; Kim, Kenneth; McIlwain, David R; Tucker, Sean N (2020). "Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study". The Lancet Infectious Diseases. 20 (4): 435–444. doi:10.1016/s1473-3099(19)30584-5. ISSN 1473-3099. PMID 31978354. S2CID 210892802.

yahoo.com (Global: 38^th place; English: 40^th place)

finance.yahoo.com

"Vaxart (VXRT) to make vaccines to check coronavirus, stock up". Yahoo Finance. Zacks Equity Research. February 3, 2020. Retrieved 1 March 2020.
"Vaxart announces positive pre-clinical data for its oral COVID-19 vaccine program". Yahoo Finance. 2020-04-21. Retrieved 2020-04-21.
"Vaxart - Top institutional holders". Yahoo Finance. 28 February 2020. Retrieved 1 March 2020.

Vaxart (English Wikipedia)

bioworld.com (Global: low place; English: low place)

bizjournals.com (Global: 407th place; English: 241st place)

businessinsider.com (Global: 140th place; English: 115th place)

markets.businessinsider.com

businesswire.com (Global: 615th place; English: 407th place)

casetext.com (Global: 4,010th place; English: 2,209th place)

cdc.gov (Global: 218th place; English: 212th place)

delaware.gov (Global: 6,775th place; English: 3,885th place)

courts.delaware.gov

doi.org (Global: 2nd place; English: 2nd place)

insidermonkey.com (Global: low place; English: low place)

nasdaq.com (Global: 2,740th place; English: 2,050th place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

polioeradication.org (Global: low place; English: low place)

researchgate.net (Global: 120th place; English: 125th place)

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

thelancet.com (Global: 2,393rd place; English: 3,174th place)

vaxart.com (Global: low place; English: low place)

investors.vaxart.com

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

yahoo.com (Global: 38th place; English: 40th place)

finance.yahoo.com

bizjournals.com (Global: 407^th place; English: 241^st place)

businessinsider.com (Global: 140^th place; English: 115^th place)

businesswire.com (Global: 615^th place; English: 407^th place)

casetext.com (Global: 4,010^th place; English: 2,209^th place)

cdc.gov (Global: 218^th place; English: 212^th place)

delaware.gov (Global: 6,775^th place; English: 3,885^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

nasdaq.com (Global: 2,740^th place; English: 2,050^th place)

nih.gov (Global: 4^th place; English: 4^th place)

researchgate.net (Global: 120^th place; English: 125^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

thelancet.com (Global: 2,393^rd place; English: 3,174^th place)

worldcat.org (Global: 5^th place; English: 5^th place)

yahoo.com (Global: 38^th place; English: 40^th place)